Sponsor:
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Code:
NCT04753879
Conditions
Metastatic Pancreatic Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Nab-paclitaxel
Gemcitabine
Cisplatin
Irinotecan
Capecitabine
Study Details
Eligibility Criteria
Study Design
Interventions and Outcome Measures
Central Contacts and Locations
More Information
Trial information was received from ClinicalTrials.gov and was last updated on 2025-11-29. This information was provided to ClinicalTrials.gov by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins on 2025-06-11.